IBDEI1HH ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24002,0)
 ;;=L97.912^^82^1041^32
 ;;^UTILITY(U,$J,358.3,24002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24002,1,3,0)
 ;;=3^Non-Prs Chr Ulc,RLL,Fat Layer Exposed
 ;;^UTILITY(U,$J,358.3,24002,1,4,0)
 ;;=4^L97.912
 ;;^UTILITY(U,$J,358.3,24002,2)
 ;;=^5133681
 ;;^UTILITY(U,$J,358.3,24003,0)
 ;;=L97.913^^82^1041^36
 ;;^UTILITY(U,$J,358.3,24003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24003,1,3,0)
 ;;=3^Non-Prs Chr Ulc,RLL,Necrosis of Muscle
 ;;^UTILITY(U,$J,358.3,24003,1,4,0)
 ;;=4^L97.913
 ;;^UTILITY(U,$J,358.3,24003,2)
 ;;=^5133683
 ;;^UTILITY(U,$J,358.3,24004,0)
 ;;=L97.914^^82^1041^35
 ;;^UTILITY(U,$J,358.3,24004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24004,1,3,0)
 ;;=3^Non-Prs Chr Ulc,RLL,Necrosis of Bone
 ;;^UTILITY(U,$J,358.3,24004,1,4,0)
 ;;=4^L97.914
 ;;^UTILITY(U,$J,358.3,24004,2)
 ;;=^5133685
 ;;^UTILITY(U,$J,358.3,24005,0)
 ;;=L97.919^^82^1041^38
 ;;^UTILITY(U,$J,358.3,24005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24005,1,3,0)
 ;;=3^Non-Prs Chr Ulc,RLL,Unspec Severity
 ;;^UTILITY(U,$J,358.3,24005,1,4,0)
 ;;=4^L97.919
 ;;^UTILITY(U,$J,358.3,24005,2)
 ;;=^5133688
 ;;^UTILITY(U,$J,358.3,24006,0)
 ;;=L97.922^^82^1041^10
 ;;^UTILITY(U,$J,358.3,24006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24006,1,3,0)
 ;;=3^Non-Prs Chr Ulc,LLL,Fat Layer Exposed
 ;;^UTILITY(U,$J,358.3,24006,1,4,0)
 ;;=4^L97.922
 ;;^UTILITY(U,$J,358.3,24006,2)
 ;;=^5133682
 ;;^UTILITY(U,$J,358.3,24007,0)
 ;;=L97.921^^82^1041^11
 ;;^UTILITY(U,$J,358.3,24007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24007,1,3,0)
 ;;=3^Non-Prs Chr Ulc,LLL,Ltd to Brkdwn Skin
 ;;^UTILITY(U,$J,358.3,24007,1,4,0)
 ;;=4^L97.921
 ;;^UTILITY(U,$J,358.3,24007,2)
 ;;=^5133680
 ;;^UTILITY(U,$J,358.3,24008,0)
 ;;=L97.923^^82^1041^8
 ;;^UTILITY(U,$J,358.3,24008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24008,1,3,0)
 ;;=3^Non-Prs Chr Ulc,LLE,Necrosis of Muscle
 ;;^UTILITY(U,$J,358.3,24008,1,4,0)
 ;;=4^L97.923
 ;;^UTILITY(U,$J,358.3,24008,2)
 ;;=^5133684
 ;;^UTILITY(U,$J,358.3,24009,0)
 ;;=L97.924^^82^1041^13
 ;;^UTILITY(U,$J,358.3,24009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24009,1,3,0)
 ;;=3^Non-Prs Chr Ulc,LLL,Necrosis of Bone
 ;;^UTILITY(U,$J,358.3,24009,1,4,0)
 ;;=4^L97.924
 ;;^UTILITY(U,$J,358.3,24009,2)
 ;;=^5133686
 ;;^UTILITY(U,$J,358.3,24010,0)
 ;;=L97.929^^82^1041^15
 ;;^UTILITY(U,$J,358.3,24010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24010,1,3,0)
 ;;=3^Non-Prs Chr Ulc,LLL,Unspec Severity
 ;;^UTILITY(U,$J,358.3,24010,1,4,0)
 ;;=4^L97.929
 ;;^UTILITY(U,$J,358.3,24010,2)
 ;;=^5133689
 ;;^UTILITY(U,$J,358.3,24011,0)
 ;;=R21.^^82^1041^58
 ;;^UTILITY(U,$J,358.3,24011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24011,1,3,0)
 ;;=3^Rash/Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,24011,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,24011,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,24012,0)
 ;;=L08.9^^82^1041^6
 ;;^UTILITY(U,$J,358.3,24012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24012,1,3,0)
 ;;=3^Local Infxn,Skin/Subcut Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,24012,1,4,0)
 ;;=4^L08.9
 ;;^UTILITY(U,$J,358.3,24012,2)
 ;;=^5009082
 ;;^UTILITY(U,$J,358.3,24013,0)
 ;;=L97.115^^82^1041^52
 ;;^UTILITY(U,$J,358.3,24013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24013,1,3,0)
 ;;=3^Non-Prs Chr Ulc,Rt Thigh,Musc Invlv w/o Necro
 ;;^UTILITY(U,$J,358.3,24013,1,4,0)
 ;;=4^L97.115
 ;;^UTILITY(U,$J,358.3,24013,2)
 ;;=^5151433
